The latest flu vaccines are now available, and just like the COVID-19 shots, it's recommended to get the flu shot in ...

The company's best days as a top pandemic vaccine supplier might be over, but it still has enough potential to be compelling.

The UK has become the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine, paving the way for mass ...

These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...

Today, Benzinga 's options scanner spotted 26 uncommon options trades for BioNTech. This isn't normal. The overall sentiment ...

Oxford Vaccine Rollout At the very end of December, UK healthcare regulator the Medicines and Healthcare Products Regulatory ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

BioNTech (BNTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

accusing the company of underpaying royalties for patents covering Penn technology used in BioNTech and Pfizer's COVID-19 ...

In the 2023-24 season, we saw more than 600,000 hospitalizations due to COVID in the U.S.” On the same day, Pfizer and BioNTech also announced that they received approval for their sBLA for an updated ...

BioNTech BNTX has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.